An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
CareDx, Inc. (NASDAQ: CDNA) will report its financial results for Q3 2022 on November 3, 2022, after market close. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties can listen by dialing 1-800-289-0438 for domestic calls or 1-323-794-2423 for international calls, using Conference ID: 2768596. The call will also be available via a live webcast on the company's investor relations website.
Positive
Scheduled Q3 2022 earnings report on November 3, 2022.
Follow-up conference call provides transparency and engagement with investors.
Negative
None.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--
CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – today announced it will report financial results for the third quarter 2022 after market close on Thursday, November 3, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Individuals interested in listening to the conference call may do so by dialing 1-800-289-0438 for domestic callers or 1-323-794-2423 for international callers. Please reference Conference ID: 2768596. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
About CareDx – The Transplant Company
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CareDx, Inc. Investor Relations
Ian Cooney 415-287-2300 x 3550
investor@caredx.com
Source: CareDx, Inc.
FAQ
When will CareDx report its Q3 2022 financial results?
CareDx will report its Q3 2022 financial results after market close on November 3, 2022.
What time is the CareDx Q3 2022 earnings call?
The Q3 2022 earnings call for CareDx is scheduled for 1:30 p.m. PT / 4:30 p.m. ET.
How can I listen to the CareDx earnings call?
You can listen to the CareDx earnings call by dialing 1-800-289-0438 for domestic callers or 1-323-794-2423 for international callers, using Conference ID: 2768596.
Where can I find the webcast for the CareDx earnings call?
The webcast for the CareDx earnings call will be available on the investor relations section of their website.
